Davis Polk is advising JP Morgan as financial adviser to Teleflex Incorporated in connection with its approximately $1 billion acquisition of Vascular Solutions, Inc. The closing of the transaction, which is expected to occur in the first half of 2017, is subject to the approval of the shareholders of Vascular Solutions and other customary closing conditions.

Teleflex Incorporated is a global provider of medical technologies with solutions in the fields of vascular and interventional access, surgical, anesthesia, cardiac care, urology, emergency medicine and respiratory care. Vascular Solutions, Inc. is an innovative medical device company that focuses on developing unique clinical solutions for coronary and peripheral vascular procedures.

The Davis Polk corporate team includes partner Alan F. Denenberg and associate Max Brunner. All members of the Davis Polk team are based in the Northern California office.

Copy link to share post